IGROV1

Rita Morigi1, Chiara Zalambani2, Giovanna Farruggia3

  • 1Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, 40126, Bologna, Italy.

概括

化合物5f选择性地向卵巢癌细胞,抑制其增殖和迁移. 它还通过降低环林D1的调节来增强对辐射的敏感性,为卵巢癌治疗提供了一个有希望的新途径.